Moderna and Merck Announce Positive Skin Cancer Vaccine Trial Results

Moderna and Merck have announced positive results from a clinical trial for an mRNA-based vaccine designed to prevent the recurrence of melanoma, a type of skin cancer. This breakthrough has significantly boosted Moderna's stock and is seen as a major step towards new cancer treatments.

19 Aug, 20:10 — 20 Aug, 09:04

Post Share

Why this matters

This story is significant because it represents a major advancement in cancer treatment, leveraging mRNA technology previously used for COVID-19 vaccines. A successful personalized cancer vaccine could revolutionize oncology by offering a more targeted approach than traditional therapies, potentially preventing recurrence in high-risk patients and opening doors for similar treatments for other cancers.

Key entitiesModerna Merck Melanoma Ralf Andersson

The Story

What 16 sources agree on, dispute, and miss

What sources agree on

Moderna and Merck announced positive results for a personalized mRNA cancer vaccine for melanoma
The vaccine, used in combination with Merck's immunotherapy drug, reduced the risk of recurrence and spread of melanoma
The mRNA technology used is the same as that behind COVID-19 vaccines
Moderna's stock price surged significantly following the announcement

Key claims4 agreed · 1 unverified

✓

Moderna's stock rose by 177% on Wednesday

agreed·die-presseNYTseeking-alpha

✓

The personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma

agreed·fazglobe-and-mailmyjoyonlinesydney-morning-herald

✓

The treatment involves pairing Merck's immunotherapy drug with a customized mRNA vaccine

agreed·japan-timesmyjoyonline

✓

The breakthrough could usher in a wave of cancer vaccines

agreed·Rapplerjapan-timesYahoo

An analyst sees more volatility ahead for Moderna's stock despite the surge

unverified·seeking-alpha

Where they diverge

Focus of the breakthrough

die-presseNYTseeking-alpha

Primarily on Moderna's stock surge and financial recovery

fazFTnational-uaeRapplerjapan-times+4 moreYahooglobe-and-mailmyjoyonlinesydney-morning-herald

Primarily on the medical breakthrough and its implications for cancer treatment

Broader public health message

irish-independentpolitiken

Emphasizes continued vigilance for skin cancer prevention and detection

die-presseNYTseeking-alphafazFT+7 morenational-uaeRapplerjapan-timesYahooglobe-and-mailmyjoyonlinesydney-morning-herald

Focuses solely on the vaccine's therapeutic potential

Coverage gaps

Discussion of the specific mechanism of personalized cancer vaccines compared to other treatments

ReportedRapplerjapan-times

Missingdie-presseNYTseeking-alpha+9

Personal anecdote about living with melanoma

Reportedpolitiken

Missingdie-presseNYTseeking-alpha+10

Coverage matrix(16 sources)

1–10 of 16

	NYT	FT	NPR	times-uk	faz	globe-and-mail	die-presse	politiken	sydney-morning-herald	Yahoo
Focus of the breakthrough
Broader public health message
Discussion of the specific mechanism of personalized cancer vaccines compared to other treatments
Personal anecdote about living with melanoma

Covered Divergent Not mentioned

The Story

Analyzing sources…

Source Diversity

Excellent (92/100)

16 sources33/33

Spectrum spread— 4/5 buckets covered25/33

Far L1

Far Left (1)

NYT

Left7

Left (7)

NPRpolitikenRapplerjapan-timesYahooglobe-and-mailsydney-morning-herald

Center2

Center (2)

FTmyjoyonline

Right6

Right (6)

die-presseseeking-alphafazirish-independentnational-uaetimes-uk

Far R

Geographic diversity— 12 regions34/34

US4UK2Austria1Denmark1Germany1Ireland1UAE1Philippines1Japan1Canada1Ghana1Australia1

Political spectrum

LeftCenterRight

nytimes

rappler

politiken

sydney-morning-herald

japan-times

yahoo

globe-and-mail

myjoyonline

seeking-alpha

die-presse

faz

irish-independent

national-uae

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

NYTcenter-leftcenter-leftanalyticalMostly FactualHighlights company's shift and stock recovery

Rapplercenter-leftcenter-leftanalyticalMostly FactualExplains scientific mechanism and broader implications

Coverage leans: balanced

The coverage is largely balanced, with most outlets focusing on the scientific breakthrough and its medical implications, while some also highlight the financial impact on Moderna.

Sources

Showing 12 of 16 sources

NYTMostly Factual4d ago

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.

By Rebecca Robbins

Read full article →

FTVery High5d ago

Moderna pins hopes on mRNA ‘game-changer’ for cancer vaccines

Technology behind blockbuster Covid-19 jabs is now yielding promising results in oncology treatment

Read full article →

NPRHigh4d ago

New mRNA vaccine could reduce the recurrence and spread of skin cancer

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

By Leila Fadel

Read full article →

times-ukMostly Factual5d ago

Landmark vaccine stops cancer returning in trial - The Times

Landmark vaccine stops cancer returning in trial The Times

Read full article →

globe-and-mailHigh5d ago

Moderna and Merck's cancer vaccine raises new treatment hope

Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna's shares surging as much as 160%.

Read full article →

sydney-morning-heraldMostly Factual5d ago

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.

By Michael Erman, Julie Steenhuysen

Read full article →

YahooMostly Factual5d ago

Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines

Read full article →

irish-independent5d ago

The Irish Independent’s View: No room for complacency on skin cancer prevention and detection

By Editorial

Read full article →

japan-timesMostly Factual5d ago

Moderna, Merck breakthrough could usher in wave of cancer vaccines

The treatment involves pairing Merck's immunotherapy drug with a customized mRNA vaccine that instructs the immune system to attack specific cancer cells.

Read full article →

seeking-alphaMixed4d ago

Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead

Read full article →

RapplerMostly Factual5d ago

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy, which revs up the immune system, personalized cancer vaccines train the immune system to specifically target mutations found only on a person's tumor

By Reuters

Read full article →

myjoyonlineMixed5d ago

Vaccine breakthrough stops cancer returning in trial

A new personalised vaccine, given in combination with a drug, has prevented skin cancer from returning in patients during a trial, marking a potentially watershed moment in cancer treatment.

By Abubakar Ibrahim

Read full article →

Coverage Timeline

First report: times-uk · 19 Aug, 20:10|Full coverage: 16 · 13h|Window: 13h

Left-leaningCenterRight-leaning

times-uk19 Aug, 20:10First to report

Landmark vaccine stops cancer returning in trial - The Times

sydney-morning-herald19 Aug, 20:55

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

1h later

myjoyonline19 Aug, 22:24

Vaccine breakthrough stops cancer returning in trial

globe-and-mail19 Aug, 23:21

Moderna and Merck's cancer vaccine raises new treatment hope

1h later

Yahoo20 Aug, 00:31

Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines

1h later

japan-times20 Aug, 01:37

Moderna, Merck breakthrough could usher in wave of cancer vaccines

1h later

Rappler20 Aug, 02:53

The Irish Independent’s View: No room for complacency on skin cancer prevention and detection

faz20 Aug, 04:43

Merck und Moderna: Positive Testergebnisse für Hautkrebs-mRNA-Impfstoff

3h later

politiken20 Aug, 07:22

Lægesekretæren hvisker: Han fik modermærkekræft tre gange af af dyrke sol. Se, hvad han gør for at undgå at dø af skræk

seeking-alpha20 Aug, 08:17

Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead

NPR20 Aug, 08:45

New mRNA vaccine could reduce the recurrence and spread of skin cancer

NYT20 Aug, 09:04

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

die-presse20 Aug, 09:14Latest update

Durchbruch bei Impfung gegen Krebs: Moderna mit Rekord-Kurssprung [premium]

Story evolution

The narrative shifted from purely reporting the scientific breakthrough to also covering the financial impact on Moderna and, in some cases, incorporating broader public health perspectives on skin cancer.

Initial Reports & HopeAug 19 evening - Aug 20 early morning

Early reports announce positive late-stage trial results for the mRNA cancer vaccine, highlighting its potential to prevent melanoma recurrence.

Financial Impact & Broader ImplicationsAug 20 morning

Coverage expands to include Moderna's significant stock surge and the broader implications for mRNA technology in oncology.

Public Health & ContextAug 20 morning

Some outlets begin to integrate public health messages about continued skin cancer prevention and detection, alongside the vaccine news.

Moderna and Merck Announce Positive Skin Cancer Vaccine Trial Results

Why this matters

The Story

What sources agree on

Key claims4 agreed · 1 unverified

Where they diverge

Coverage gaps

Coverage matrix(16 sources)

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Moderna pins hopes on mRNA ‘game-changer’ for cancer vaccines

New mRNA vaccine could reduce the recurrence and spread of skin cancer

Landmark vaccine stops cancer returning in trial - The Times

Moderna and Merck's cancer vaccine raises new treatment hope

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines

The Irish Independent’s View: No room for complacency on skin cancer prevention and detection

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Vaccine breakthrough stops cancer returning in trial

Coverage Timeline

Landmark vaccine stops cancer returning in trial - The Times

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Vaccine breakthrough stops cancer returning in trial

Moderna and Merck's cancer vaccine raises new treatment hope

Analysis-Moderna, Merck breakthrough could usher in wave of cancer vaccines

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Skin cancer breakthrough delivers second act for Moderna's mRNA vaccines

Moderna pins hopes on mRNA ‘game-changer’ for cancer vaccines

The Irish Independent’s View: No room for complacency on skin cancer prevention and detection

Merck und Moderna: Positive Testergebnisse für Hautkrebs-mRNA-Impfstoff

Lægesekretæren hvisker: Han fik modermærkekræft tre gange af af dyrke sol. Se, hvad han gør for at undgå at dø af skræk

Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead

New mRNA vaccine could reduce the recurrence and spread of skin cancer

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Durchbruch bei Impfung gegen Krebs: Moderna mit Rekord-Kurssprung [premium]

Story evolution

Related Stories

Study Links Breakfast Timing to Lifespan

Exploring Mental Health and Wellness Beyond Traditional Therapy, Including Sound Therapy

Health Company Admits Maradona Test Mix-Up in Death Trial

FDA Clears Roche and Eli Lilly's Alzheimer's Blood Test

Why this matters

The Story

What sources agree on

Key claims4 agreed · 1 unverified

Where they diverge

Coverage gaps

Coverage matrix(16 sources)

Story evolution

Political spectrum